Search - tctmd.com

Displaying 541 - 560 of 600

Sort: Relevancy | Date

News Daily News

Pre-oxygenation Reduces Contrast Nephropathy in Elective PCI Patients

Jason Kahn

May 17, 2013

News Daily News

Meta-analysis: Renal Denervation Effective Regardless of Catheter Type

L.A. McKeown

May 17, 2013

News Daily News

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

April 26, 2013

News Industry News

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

March 09, 2013

News Conference News ACC 2013

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

L.A. McKeown

March 08, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Industry News

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

February 14, 2013

News Daily News

Renal Denervation Appears Safe for Patients with Kidney Dysfunction

January 09, 2013

News Daily News

Carotid Stenting Yields More DWI Lesions Than Endarterectomy

January 07, 2013

News Daily News

Renal Denervation Shows Sustained BP Improvements at 1 Year

Jason Kahn

December 26, 2012

News Daily News

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Industry News

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

December 16, 2012

News Industry News

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

November 04, 2012

News Conference News AHA 2012

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Jason Kahn

November 04, 2012

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

News Industry News

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

October 22, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

Advertisement

Pre-oxygenation Reduces Contrast Nephropathy in Elective PCI Patients

Meta-analysis: Renal Denervation Effective Regardless of Catheter Type

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

Renal Denervation Appears Safe for Patients with Kidney Dysfunction

Carotid Stenting Yields More DWI Lesions Than Endarterectomy

Renal Denervation Shows Sustained BP Improvements at 1 Year

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

More Data Needed on Renal Denervation

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content